TD Asset Management’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
BPC
CS
AWA
PVI
BPCE
EDRH
TD Asset Management's SOPH Position: Q3 2023 in Review
TD Asset Management sold out of SOPHiA GENETICS (SOPH) in Q3 2023, closing a stake of 68,753 shares — an estimated $308K sold.
TD Asset Management first reported a position in SOPH in Q3 2021 and held it in 8 quarters. The position peaked at $2.05M in Q3 2021. 32 funds tracked by Wall St. Rank hold SOPH as of Q3 2023.
- TD Asset Management reported no remaining SOPHiA GENETICS position as of Q3 2023 after selling out during the quarter.
- TD Asset Management sold 68,753 SOPHiA GENETICS shares in Q3 2023, an estimated $308K.
- TD Asset Management first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 8 quarters.
- TD Asset Management's SOPHiA GENETICS position peaked at $2.05M in Q3 2021.
- 32 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2023.
Based on TD Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.